尼莫地平联合醒脑静治疗急性脑出血的临床疗效

Clinical Efficacy of Nimodipine Combined with Xingnaojing in the Treatment of Acute Cerebral Hemorrhage

目的探讨尼莫地平联合醒脑静治疗急性脑出血的临床疗效。方法选择2018年1月至2019年12月我院收治的40例急性脑出血患者,随机分为对照组(20例,采用尼莫地平治疗)和观察组(20例,采用尼莫地平联合醒脑静治疗)。对比两组患者的治疗效果,用药前及药物疗程完成后的血肿情况。结果药物疗程完成后,观察组的血肿量少于对照组(P<0.05)。观察组治疗总有效率高于对照组(P<0.05)。结论尼莫地平联合醒脑静治疗急性脑出血患者,能够改善其脑出血症状,降低其脑部血肿量,避免患者脑组织受到过多的损伤。

Objective To explore the clinical efficacy of nimodipine combined with Xingnaojing in the treatment of acute cerebral hemorrhage.Methods 40 patients with acute cerebral hemorrhage admitted to our hospital from January 2018 to December 2019 were selected and randomly divided into control group(20 cases,treated with nimodipine)and observation group(20 cases,treated with nimodipine combined with Xingnaojing).The treatment effect,and the hematoma conditions before and after the drug course were compared between the two groups.Results After the drug course,the hematoma volume of the observation group was less than that of the control group(P<0.05).The total effective rate of treatment in the observation group was higher than that in the control group(P<0.05).Conclusions Nimodipine combined with Xingnaojing in the treatment of acute cerebral hemorrhage can improve the symptoms of cerebral hemorrhage,reduce the brain hematoma volume,and avoid patients'brain tissues from being damaged too much.